Reliv International net income down in 2009 third quarter

Reliv International, Inc. (Nasdaq: RELV), a nutrition and direct selling company, today reported third-quarter net sales of $20.9 million vs. $23.9 million in the same quarter of 2008.

Net income was $324,000 vs. $536,000 in the 2008 third quarter, and earnings per diluted share were $0.03 compared to $0.04 in the same quarter last year.

In the United States, net sales totaled $18.3 million compared to $20.8 million in the third quarter of 2008. Net sales outside of the U.S. declined by approximately 14 percent. Excluding the impact of foreign currency fluctuations, however, the decline in foreign sales was about 5 percent.

Reliv also announced that it is reducing its dividend from $0.05 per share to $0.02 per share. For 2009, Reliv's annual dividend will be $0.07 rather than $0.10 per share.

"Despite the decline in our performance compared to last year's third quarter, we saw glimmers of light that we hope will shine brighter as we move into 2010," said Robert L. Montgomery, chairman, president and chief executive officer. "We achieved a five percent increase in the number of new distributors along with an increase in the number of orders this quarter over the third quarter of 2008," he said.

"This year we also reported a sequential increase in net sales from the second quarter to the third quarter for the first time since 2006," Montgomery said. "In addition, the number of orders and the size of the average order are up sequentially."

"The highlight of the third quarter was our international conference in St. Louis, where we introduced a new line of products under the Relivables name as well as a number of new business tools for distributors. All have been well received," Montgomery said.

For the first nine months of 2009, net sales totaled $64.7 million, down about 15 percent compared to the same period last year. U.S. sales decreased approximately 13 percent, while sales outside of the U.S. were down about 27 percent. Excluding foreign currency fluctuations, foreign sales were down 13.5 percent.

Net income for the first three quarters of this year equaled $1.7 million compared to $2.6 million for the first three quarters of 2008. Diluted earnings per share for the period equaled $0.13, down from diluted earnings per share of $0.17 for the first nine months of last year.

Reliv generated cash from operating activities of $4.8 million during the first nine months of 2009, an increase of approximately 34 percent over cash generated from operations during the same period last year. Reducing inventory levels was a key factor in the increase.

"In the fourth quarter, we are continuing a series of special events called the Financial Freedom Tour, launched earlier this year, in which we highlight the Reliv business opportunity. We expect to share the opportunity with a couple of thousand existing and potential distributors between October and November through these events," Montgomery said.

Dividend reduction

Commenting on the reduction in Reliv's dividend, Steven D. Albright, senior vice president and chief financial officer, said, "This is a difficult decision but we're confident it's the right one for Reliv. With profits down, we can invest the cost savings from the dividend to strengthen our business overall."

The dividend will be paid to all shareholders of record as of Nov. 9, 2009, to be paid on or about Nov. 19, 2009.

Reliv will host a conference call to discuss third-quarter earnings with investors. The conference call will be on October 29, 2009 at 1:00 p.m. Eastern. The dial-in number is 866-272-9941. The participant passcode is 10757749. A replay will be available for one week at 888-286-8010 using the passcode 37679647. A live webcast is available on the Investor Relations section of Reliv's Web site at: https://reliv.com/

An online archive of the webcast will be on Reliv's Web site in the Investor Relations section, 24 hours after call concludes.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How nutrition and telomere dynamics shape beauty and aging in women